Nervous System

NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Company Title Company Description City
Accord Healthcare Inc.

Accord Healthcare develops and manufactures generic pharmaceuticals. Their portfolio includes therapeutics in oncology, cardiology, neurology, nephrology, urology, psychiatry, diabetes and pain management. The North Carolina location is a sales office.

Durham
AegisCN LLC

AegisCN develops technologies and treatments targeting neurological diseases and inflammation.

Durham
Aestas Pharma Inc.

Asetas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the early treatment and reversal of Alzheimer’s and Parkinson’s disease when clinical signs are not yet pronounced.

Lewisville
Arrivo BioVentures LLC

Arrivo BioVentures accelerates biologics and small molecules from IND/phase one through proof-of-concept, with biologics in development for dermatologic conditions and hearing loss.

Morrisville
Atrium Health Division of Therapeutic Research and Development

The Division of Therapeutic Research and Development at Atrium Health conducts clinical studies, patient-focused translational research and outcomes research.

Charlotte
Axovant Sciences Inc.

Axovant Sciences develops gene therapies to treat neurologic conditions.

Durham
Biogen

Biogen discovers, develops and manufactures therapies for serious neurological diseases. Its Drug Substance Campus in RTP is home to biologics production and a patient services contact center.

Research Triangle Park
Biogen (Oral Solid Dose Facility)

Biogen discovers, develops and manufactures therapies for serious neurological diseases. This site houses oral solid dose and anti-sense oligonucleotide production, packaging and fill/finish operations, as well as a Global Business Services center.

Research Triangle Park
Catalyst Medicine LLC

Catalyst Medicine designs, develops and commercializes Class 1 and Class 2 medical devices in the areas of neurology, orthopedics, cardiology and plastic surgery.

Durham
Chaperone Therapeutics Inc.

Chaperone Therapeutics develops disease-modifying therapies for neurodegenerative and rare diseases caused by protein misfolding.

Chapel Hill
Clinipace Worldwide Inc.

Clinipace provides clinical research services to pharmaceutical, biotechnology, and medical device companies globally, working across all major therapeutic areas including oncology, gastroenterology, and nephrology and urology.

Morrisville
Cloud Pharmaceuticals Inc.

Cloud Pharmaceuticals designs and develops novel drug molecules using computational design for a wide range of therapeutic areas including cancer, inflammation, CNS disorders and rare diseases.

Research Triangle Park
Cognosci Inc.

Cognosci develops neurorestorative therapies for Alzheimer's disease, multiple sclerosis, traumatic brain injury, nerve crush and other disease and trauma indications.

Durham
Dina Pharmaceuticals Inc.

Dina Pharmaceuticals is developing a treatment for Levodopa-Induced Dyskinesia (LID) associated with Parkinson’s disease.

Raleigh
Eisai Inc.

Eisai discovers, develops and markets pharmaceuticals in neurology and oncology-critical care. This site supports global partnerships, quality assurance and supply chain for the company.

Raleigh
ENVIGEN Pharmaceuticals Inc.

ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders.

Raleigh
Falcon Therapeutics Inc.

Falcon Therapeutics is developing personalized neural stem cell therapies to treat cancers.

Durham
GBM Pharma Inc.

GBM Pharma develops drugs for the treatment of glioblastoma multiforme.

Durham
Generys Biopharmaceuticals Corp.

Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis.

Chapel Hill
Grifols

Grifols develops and produces plasma-derived medicines to treat chronic and acute conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology.

Research Triangle Park
GSK

GSK develops and manufactures vaccines, medicines and consumer healthcare products, with a focus on science related to the immune system, use of genetics and advanced technologies.

Research Triangle Park
Gyrus Pharmaceuticals Inc.

Gyrus Pharmaceuticals is developing treatments for serious diseases of the central nervous system using proprietary therapeutic agents and nanoparticles for noninvasive delivery to the CNS.

Chapel Hill
Howard Associates LLC

Howard Associates offers preclinical contract research to the pharma industry, primarily on rodent models to predict the efficacy of experimental compounds for CNS diseases and to predict side effects. The company also offers science editing and writing.

Research Triangle Park
Karamedica Inc.

Karamedica has developed a plasma treatment system to decontaminate chitosan, a biopolymer found in the shells of shrimps and crabs. Karamedica is currently developing a nanoparticle therapy for cerebral amyloid angiopathy.

Raleigh
Krenitsky Pharmaceuticals Inc.

Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system.

Chapel Hill
Lundbeck NA Ltd.

Lundbeck is a pharmaceutical development company that acquires and develops products for the treatment of various human diseases, including central nervous system disorders.

Charlotte
Merz North America Inc.

Merz North America develops and commercializes treatment solutions in aesthetics and neurosciences.

Raleigh
Migraine Solutions LLC

Migraine Solutions is developing Relaspen, an intra-nasal medical device which applies lidocaine directly to the SPG (Sphenopataline Ganglion) nerve, reducing migraines.

Asheville
Mirrored Motion Works Inc

Mirrored Motion Works designs and develops rehabilitation machines to improve hand and upper limb function in individuals with weakness, including stroke patients.

Cary
NDI Medical LLC

NDI is a medical device commercialization and venture capital firm focused on funding and developing neurodevice technologies for unmet health needs.

Chapel Hill
NeuroPro Therapeutics Inc.

NeurPro Therapeutics is developing new drugs to treat epilepsy and other CNS disorders.

Bahama
NeuroVice LLC

NeuroVice is developing a tongue protector to prevent tongue-biting and drooling during a seizure.

Cary
North Carolina Clinical Research

North Carolina Clinical Research conducts phase one through four trials at its outpatient clinical research facility. Study indications include allergy (seasonal and perennial), asthma, COPD, vaccine, migraine and bioequivalent studies.

Raleigh
OD Consulting and Neurological Services PLLC

OD Consulting and Neurological Services provides consulting in the areas of clinical development, safety monitoring and regulatory submissions of CNS-focused drugs and devices, and healthcare training and clinical services.

Chapel Hill
Optimas Wellness LLC

Optimas Wellness develops personalized wellness plans based on DNA analysis to help prevent or delay the development of late onset Alzheimer's disease.

Charlotte
Osmotica Pharmaceutical Corp.

Osmotica Pharmaceutical specializes in drug-delivery technologies and neurology-based therapies, including a treatment for Parkinson's disease.

Wilmington
Pfizer Inc. (Chapel Hill)

Pfizer's Bamboo Therapeutics develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases, including Giant Axonal Neuropathy (GAN), Canavan Disease, Friedreich's Ataxia and Duchenne Muscular Dystrophy (DMD).

Chapel Hill
Praetego Inc.

Praetego is developing technology to protect against the pathology of oxidative stress. Targets include acute kidney injury (AKI), traumatic brain injury (TBI) and diabetic complications.

Durham
Pulvinar Neuro LLC

Pulvinar Neuro develops and markets a tDCS/tACS research solution for non-invasive brain stimulation research.

Chapel Hill
Resilio Therapeutics LLC

Resilio Therapeutics is developing treatments for neurodegenerative diseases such as Alzheimer's Disease.

Research Triangle Park
Revivo Therapeutics Inc.

Revivo Therapeutics is a clinical stage company developing therapies for cognitive dysfunction, anxiety and neuroprotection.

Durham
Roivant Sciences Inc.

Roivant Sciences acquires drug candidates or partners with the biopharma industry to complete the clinical development of shelved product candidates. Therapeutic areas include neurology, dermatology, hepatology, oncology, endocrinology and rare disease.

Durham
RTI International

RTI, an independent, nonprofit institute, offers scientific and technical expertise in social and laboratory sciences, engineering and international development to government and commercial clients worldwide.

Research Triangle Park
Sage Central

Sage Central is the patient support center for Sage Therapeutics, a pharmaceutical company that develops treatments for brain disorders, including postpartum depression (PPD).

Raleigh
Sentiens LLC

Sentiens develops nutraceutical products targeting addictive behavior.

Charlotte
SiNON Therapeutics

SiNON is developing technology to treat neurological diseases by increasing the ability of drugs to cross the Blood Brain Barrier (BBB).

Research Triangle Park
SpringWorks Therapeutics LLC

SpringWorks Therapeutics develops standalone and combination therapies with a focus on rare diseases and oncology, including plexiform neurofibroma, desmoid tumors, RAS/RAF mutant solid tumors and CNS disorders. Its initial portfolio is from Pfizer.

Durham
StrideBio Inc.

StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs).

Research Triangle Park
Synthon Pharmaceuticals Inc.

Synthon Pharmaceuticals develops and manufactures generics, as well as specialty pharmaceuticals and biosimilars in key therapeutic areas of oncology and multiple sclerosis. The Durham location is a regulatory office.

Durham
T3D Therapeutics Inc.

T3D Therapeutics is developing a disease-modifying drug therapy for Alzheimer’s disease that may improve multiple disease defects. T3D is also targeting treatments for other neurodegenerative diseases including Huntington's Disease.

Research Triangle Park
Tellus Therapeutics Inc.

Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury.

Hillsborough
Tenax Therapeutics Inc.

Tenax Therapeutics develops and commercializes pharmaceutical products for the critical care market.

Morrisville
TregTherapeutics Inc.

TregTherapeutics develops tolerogenic therapies to treat autoimmune disesase. The company is currently developing a tolerogenic vaccine to eradicate multiple sclerosis.

Chapel Hill
Triangle BioSystems International

Triangle Biosystems develops, produces, markets and supports biomedical signal processing products that advance the research and performance capabilities of its customers in the neurophysiology and ultrasound marketplace.

Durham
Triangle Research Solutions Inc.

Triangle Research Solutions provides clinical trial services such as project management, AE/SAE monitoring, CRF design, IVRS consultation, site recruitment, patient recruitment, and protocol consultation.

Hillsborough
UCB Biosciences Inc.

UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis.

Raleigh
vTv Therapeutics LLC

vTv Therapeutics is developing drug candidates to fill significant unmet medical needs such as Alzheimer’s disease, Type 2 diabetes and inflammatory disorders.

High Point
Wilmington Pharmaceuticals LLC

Wilmington Pharmaceuticals develops fast-dissolving dosage forms for established medicines.

Wilmington
Worldwide Clinical Trials Inc.

Worldwide Clinical Trials provides phase one through phase four drug development services to the pharmaceutical and biotechnology industries.

Morrisville
Zinfandel Pharmaceuticals Inc.

Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies.

Chapel Hill